AAAAAA
Results:
1-14
|
Results: 14
Authors:
Sibinga, CTS
Citation: Cts. Sibinga, Risk management: an important tool for improving quality, TRANSF CL B, 8(3), 2001, pp. 214-217
Authors:
Sibinga, CTS
Citation: Cts. Sibinga, Inappropriate use of blood: is the problem intractable?, MED J AUST, 175(7), 2001, pp. 348-349
Authors:
Sibinga, CTS
Citation: Cts. Sibinga, Transfusion medicine in developing countries, TR MED REV, 14(3), 2000, pp. 269-274
Authors:
Hovenga, S
de Wolf, JT
Guikema, JEJ
Klip, H
Smit, JW
Sibinga, CTS
Bos, NA
Vellenga, E
Citation: S. Hovenga et al., Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation, BONE MAR TR, 25(7), 2000, pp. 723-728
Authors:
Weinreich, SS
Remmerswaal, EBM
Laport, R
van Rhenen, DJ
Rombout-Sastrienkova, E
Sibinga, CTS
Vrielink, H
Boog, CJP
Citation: Ss. Weinreich et al., Variable leukocyte composition of red blood cell concentrates prepared in top-bottom systems: Possible implications for pre-transplant blood transfusion, VOX SANGUIN, 79(2), 2000, pp. 83-86
Authors:
van Delden, CJ
Faber, RD
de Wit, HJC
Sibinga, CTS
Citation: Cj. Van Delden et al., Preparation of leukocyte-poor platelet concentrates via a short, hard spinof a pool of buffy coats, VOX SANGUIN, 78(3), 2000, pp. 164-170
Authors:
Elting, JW
de Jager, AEJ
Teelken, AW
Schaaf, MJ
Maurits, NM
van der Naalt, J
Sibinga, CTS
Sulter, GA
De Keyser, J
Citation: Jw. Elting et al., Comparison of serum S-100 protein levels following stroke and traumatic brain injury, J NEUR SCI, 181(1-2), 2000, pp. 104-110
Authors:
Drayer, AL
Sibinga, CTS
Blom, NR
de Wolf, JTM
Vellenga, E
Citation: Al. Drayer et al., The in vitro effects of cytokines on expansion and migration of megakaryocyte progenitors, BR J HAEM, 109(4), 2000, pp. 776-784
Authors:
Wymenga, ANM
van der Graaf, WTA
Kema, IP
Sibinga, CTS
de Vries, EGE
Mulder, NH
Citation: Anm. Wymenga et al., Effects of peripheral stem cell or bone marrow reinfusion on peripheral serotonin metabolism, BONE MAR TR, 24(9), 1999, pp. 1015-1018
Authors:
Sibinga, CTS
Citation: Cts. Sibinga, Haemovigilance systems, VOX SANGUIN, 77(2), 1999, pp. 116-117
Authors:
Fratantoni, JC
Sibinga, CTS
Spence, RK
Murphy, W
van Aken, WG
Laupacis, A
de Wolf, JTM
AuBuchon, JP
Lust, A
de Wit, HJC
Tahhan, HR
van Heukelom, LHS
Valeri, CR
Citation: Jc. Fratantoni et al., The clinical setting: How to optimise supportive haemotherapy - Discussion, DEV HEMATOL, 33, 1998, pp. 43-52
Authors:
Valeri, CR
de Wit, HJC
Sibinga, CTS
de Vries, EGE
AuBuchon, JP
Winslow, RM
Boralessa, H
Fratantoni, JC
Middleton, S
de Leij, L
Goodnough, LT
Nicolson, DM
Lust, A
Citation: Cr. Valeri et al., Chemical and biological alternatives - Discussion, DEV HEMATOL, 33, 1998, pp. 123-131
Authors:
Goodnough, LT
de Wit, HJC
Fratantoni, JC
Baele, P
Rocha, V
Elias, MK
Falkenburg, F
Spence, RK
Koopman-van Gemert, AWMM
Sibinga, CTS
Fergusson, D
McClelland, DBL
AuBuchon, JP
Citation: Lt. Goodnough et al., Alternative approaches in clinical practice - Discussion, DEV HEMATOL, 33, 1998, pp. 197-205
Authors:
Fratantoni, JC
Das, PC
Laupacis, A
AuBuchon, JP
Brand, A
Hebert, PC
Sibinga, CTS
McClelland, B
Winslow, RM
Valeri, CR
Lust, A
Citation: Jc. Fratantoni et al., The balance of risks, benefits and costs - Discussion, DEV HEMATOL, 33, 1998, pp. 245-252
Risultati:
1-14
|